Business
Guardant Health Announces Additions to Leadership Team
Ines Dahne-Steuber named as chief operating officer Darya Chudova promoted to chief technology officer PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health,
About this update from Guardant Health, Inc.
[{"type":"text","content":"\n\nInes Dahne-Steuber named as chief operating officer\n\n\n\nDarya Chudova promoted to chief technology officer\n\n\n\n \n\n\n PALO ALTO, Calif.--(BUSINESS WIRE)--\nGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the expansion of its leadership team with the addition of Ines Dahne-Steuber as chief operating officer and the promotion of Darya Chudova to chief technology officer.\n\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230508005605/en/Ines Dahne-Steuber, Chief Operating Officer (Photo: Busines Wire)\n“At Guardant, we have built one of the most transformative platforms in diagnostics and we think extensively about how we get work done more efficiently, from development through delivery, to fulfill our primary mission of helping patients,” said Helmy Eltoukhy, Guardant Health chairman and co-CEO. “As we scale our global operations, with an eye toward future product launches, Ines and Darya are uniquely qualified to help us succeed in this next exciting chapter of our journey.”\n\n\nInes Dahne-Steuber brings over 20 years of leadership and strategic expertise in healthcare operations. Prior to joining Guardant Health, she served as senior vice president of operational excellence and president of Spectra Laboratories at Fresenius Medical Care North America. Spectra Laboratories performs 100 million clinical and environmental tests serving over 200,000 dialysis patients per year. Prior to Fresenius Medical Care, she served in various leadership roles at Quest Diagnostics, most recently as general manager for oncology and vice president of healthcare IT solutions. Ms. Dahne-Steuber earned her Bachelor of Arts and Master’s degrees at Humboldt University in Berlin, Germany.\n\n\nDarya Chudova has been with Guardant Health for eight years, most recently serving as the senior vice president of technology. In this role, she initially focused on leading technical development of Guardant360 LDT and CDx products improving the precision, robustness and accessibility of Guardant’s liquid biopsy tests. Most recently, she has led the development of Guardant’s ShieldTM technology for blood-based colorectal cancer screening, which is currently under review with the U.S. Food and Drug Administration. Prior to Guardant, Darya successfully...